During the COVID-19 pandemic, dialysis access in India collapsed as overwhelmed hospitals, restricted movement, and closed centers left patients unable to receive the life-sustaining treatment they needed. Front-line nephrologists witnessed the devastating consequences—patients missing sessions, deteriorating rapidly, and in some cases dying—not from the virus itself but from lack of timely dialysis. Faced with this crisis, a group of committed kidney specialists asked, “If not us, then who?” and founded Renacare Center for Kidney Disease and Research Pvt. Ltd®.

Guided by principles of ethical, protocol-driven care that place nephrologists at the heart of treatment, they set out not merely to create another dialysis chain but to establish a new standard of clinical oversight, dignity, and safety for kidney patients across India. In response to the pandemic’s challenges, Renacare also pioneered a Home Hemodialysis Program, bringing hospital-grade care into patients’ homes to ensure safety, flexibility, and ongoing specialist supervision.